Answers are grounded in this paper and cite their sources.
Recent advances in digital microfluidics have led to tremendous interest in miniaturized lab-on-chip devices for biochemical analysis. Synthesis tools have also emerged for the automated design of lab-on-chip from the specifications of laboratory protocols. However, none of these tools consider control flow or address the problem of recovering from fluidic errors that can occur during on-chip bioassay execution. We present a synthesis method that incorporates control paths and an error-recovery mechanism in the design of a digital microfluidic lab-on-chip. Based on error-propagation estimates, we determine the best locations for fluidic checkpoints during biochip synthesis. A microcontroller coordinates the implementation of the control-flow-based bioassay by intercepting the synthesis results that are mapped to the software programs. Real-life bioassay applications are used as case studies to evaluate the proposed design method. For a representative protein assay, compared to a baseline chip design, the biochip with a control path can reduce the completion time by 30% when errors occur during the implementation of the bioassay.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: